MaxCyte, Inc. Shares Outstanding
MaxCyte, Inc. (MXCT) had Shares Outstanding of 106.13 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-13
- 2026-06-30: Shares outstanding (split-adjusted) 106.13M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 107.12M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 106.79M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 106.64M shares; Shares authorized (split-adjusted) 400.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 106.13M shares 10-Q · filed 2026-08-13 | 400.00M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 107.12M shares 10-Q · filed 2026-05-13 | 400.00M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 106.79M shares 10-Q · filed 2026-08-13 | 400.00M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 106.64M shares 10-Q · filed 2025-11-13 | 400.00M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 106.59M shares 10-Q · filed 2025-08-06 | 400.00M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 106.31M shares 10-Q · filed 2025-05-08 | 400.00M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 105.71M shares 10-K · filed 2026-03-25 | 400.00M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 105.30M shares 10-Q · filed 2024-11-06 | 400.00M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 104.82M shares 10-Q · filed 2024-08-06 | 400.00M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 104.41M shares 10-Q · filed 2024-05-07 | 400.00M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 103.96M shares 10-K · filed 2025-03-11 | 400.00M shares 10-K · filed 2025-03-11 |
| 2023-09-30 | 103.55M shares 10-Q · filed 2023-11-08 | 400.00M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 103.13M shares 10-Q · filed 2023-08-09 | 400.00M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 102.90M shares 10-Q · filed 2023-05-10 | 400.00M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 102.40M shares 10-K · filed 2024-03-12 | 400.00M shares 10-K · filed 2024-03-12 |
| 2022-09-30 | 101.90M shares 10-Q · filed 2022-11-09 | 400.00M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 101.66M shares 10-Q · filed 2022-08-10 | 400.00M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 101.51M shares 10-Q · filed 2022-05-09 | 400.00M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 101.20M shares 10-K · filed 2023-03-15 | 400.00M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 100.43M shares 10-Q · filed 2021-11-10 | 200.00M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 84.72M shares 10-Q · filed 2021-09-13 | 200.00M shares 10-Q · filed 2021-09-13 |
| 2020-12-31 | 77.38M shares 10-K · filed 2022-03-22 | 200.00M shares 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |